CS logo
small CS logo
Hamatologisch - Onkologische Praxis Wurzburg

Wurzburg, Germany
Hematologist in Würzburg, Bavaria
Schweinfurter Str. 7, 97080 Würzburg

About Hamatologisch - Onkologische Praxis Wurzburg


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Hamatologisch - Onkologische Praxis Wurzburg


During the past decade, Hamatologisch - Onkologische Praxis Wurzburg conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
2014-06-01
2023-12-31
Recruiting
126
Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
2015-07-23
2019-02-27
Completed
387
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
2016-07-25
2020-01-29
Completed
509
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
2017-09-29
2021-04-07
Terminated
50
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
2017-07-20
2019-02-05
Terminated
119
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
2017-12-07
2021-03-31
Terminated
264
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
2018-07-13
2019-10-21
Completed
233
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
2018-12-04
2023-12-29
Active, not recruiting
128

Rows per page:

1–18 of 18

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hamatologisch - Onkologische Praxis Wurzburg" #1 sponsor was "German CLL Study Group" with 10 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Celgene" with 2 trials sponsored, "Celgene Corporation" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hamatologisch - Onkologische Praxis Wurzburg" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Hamatologisch - Onkologische Praxis Wurzburg


According to Clinical.Site data, the most researched conditions in "Hamatologisch - Onkologische Praxis Wurzburg" are "Chronic Lymphocytic Leukemia" (5 trials), "Breast Cancer" (3 trials), "Chronic Lymphoid Leukemia" (3 trials), "Leukemia" (3 trials) and "Anemia" (1 trials). Many other conditions were trialed in "Hamatologisch - Onkologische Praxis Wurzburg" in a lesser frequency.

Clinical Trials Intervention Types at Hamatologisch - Onkologische Praxis Wurzburg


Most popular intervention types in "Hamatologisch - Onkologische Praxis Wurzburg" are "Drug" (18 trials), "Biological" (8 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Obinutuzumab" (4 trials), "Cyclophosphamide" (3 trials), "Fludarabine" (3 trials), "Rituximab" (3 trials) and "Bendamustine" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hamatologisch - Onkologische Praxis Wurzburg


The vast majority of trials in "Hamatologisch - Onkologische Praxis Wurzburg" are 21 trials for "All" genders.

Clinical Trials Status at Hamatologisch - Onkologische Praxis Wurzburg


Currently, there are NaN active trials in "Hamatologisch - Onkologische Praxis Wurzburg". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hamatologisch - Onkologische Praxis Wurzburg, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hamatologisch - Onkologische Praxis Wurzburg, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status